Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
More Medical Lab Tests Will Soon Face Federal Scrutiny, FDA Says
MONDAY, April 29, 2024 -- Laboratory tests used by millions of Americans are soon to be classified as medical devices, and as such be regulated by U.S. Food...
Intensive HTN Treatment Cuts Early T2D Diagnosis-Linked CVD Event Risk
MONDAY, April 29, 2024 -- More intensive hypertensive therapy significantly reduces the excess risk for cardiovascular disease (CVD) events associated with...
Multisite QI Collaborative Increases Appropriate Pediatric Antibiotic Use
MONDAY, April 29, 2024 -- A multisite collaborative increases appropriate antibiotic use for pediatric community-acquired pneumonia, skin and soft tissue...
Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas
MONDAY, April 29, 2024 -- For patients with metastatic pheochromocytomas and paragangliomas (MPPGs), an antiangiogenic multi-tyrosine kinase inhibitor...
Home Vision Tests Offer Limited Diagnostic Accuracy for Neovascular AMD
MONDAY, April 29, 2024 -- No home-monitoring vision test has the diagnostic accuracy of hospital eye service follow-up clinics to identify active neovascular...
Mental, Social Disturbances Increased for Children With Prior Concussion
MONDAY, April 29, 2024 -- The rate of mental and social disturbances is higher for U.S. children with prior concussion or brain injury symptoms/diagnosis...
FDA Says First Round of Tests Show No Live Virus in Pasteurized Milk
MONDAY, April 29, 2024 -- Live bird flu virus has not been found in any of the first batch of retail milk samples tested, federal health officials said...
King Charles Returns to Duties After Cancer Treatment
MONDAY, April 29, 2024 -- Britain's King Charles III is back to resuming his royal duties following treatment for cancer, Buckingham Palace announced...
Biden Administration Delays Menthol Cigarette Ban
MONDAY, April 29, 2024 -- A long-awaited ban on menthol cigarettes has been delayed indefinitely, the Biden administration said Friday. “This rule has...
Scientists Discover Cause of Rare Movement Disorder
MONDAY, April 29, 2024 -- Researchers have conclusively identified the genetic cause of a rare, progressive movement disorder. A rare extra-long version of a...
FDA Approves Beqvez (fidanacogene elaparvovec-dzkt) One-Time Gene Therapy for Adults with Hemophilia B
NEW YORK--(BUSINESS WIRE) April 26, 2024 -- Pfizer Inc. (NYSE: PFE)announced today that the U.S. Food and Drug Administration (FDA) has approved Beqvez&trade...
FDA Approves Pivya (pivmecillinam) for the Treatment of Uncomplicated Urinary Tract Infections
April 24, 2024 -- Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated...
Novartis Radioligand Therapy Lutathera FDA Approved as First Medicine Specifically for Pediatric Patients with Gastroenteropancreatic Neuroendocrine Tumors
Basel, April 23, 2024 -- Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Lutathera (USAN: lutetium Lu 177 dotatate / INN...
FDA Grants Accelerated Approval for Ojemda (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma
BRISBANE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a...
Abeona Therapeutics Provides Regulatory Update on Pz-cel
CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced a regulatory update for prademagene zamikeracel (pz-cel)...
FDA Approves Anktiva (nogapendekin alfa inbakicept-pmln) Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
CULVER CITY, Calif., April 22, 2024 -- ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration...
Supernus Provides Regulatory Update for SPN-830
ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Stealth Biotherapeutics Announces FDA Acceptance of New Drug Application for Elamipretide for the Treatment of Barth Syndrome
NEEDHAM, Mass., April 8, 2024 /PRNewswire/ — Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and...
Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
DUBLIN, April 2, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has completed the rolling submission of a...
Datopotamab Deruxtecan Biologics License Application Accepted in the US for Patients with Previously Treated Metastatic HR-Positive, HER2-Negative Breast Cancer
2 April 2024 -- AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US...
Lower Dose of Mpox Vaccine is Safe and Generates Six-Week Antibody Response Equivalent to Standard Regimen
April 27, 2024 -- A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard...
Analysis Identifies 50 New Genomic Regions Associated with Kidney Cancer Risk
April 26, 2024 -- In a new analysis of genetic susceptibility to kidney cancer, an international team of researchers has identified 50 new areas across the...
Experimental NIH Malaria Monoclonal Antibody Protective in Malian Children
April 26, 2024 -- One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the...
Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome Testing
FORT MYERS, Fla., April 25, 2024. Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist and hematologist Ernesto Bustinza-Linares...
Gene-Based Therapy Restores Cellular Development and Function in Brain Cells From People With Timothy Syndrome
April 24, 2024 -- In a proof-of-concept study, researchers demonstrated the effectiveness of a potential new therapy for Timothy syndrome, an often...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.